These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6634496)

  • 1. [Development of malignant lymphoma during anticonvulsant therapy].
    Gabryś K; Medraś E; Kowalski P; Gola A
    Pol Tyg Lek; 1983 Apr; 38(16):505-7. PubMed ID: 6634496
    [No Abstract]   [Full Text] [Related]  

  • 2. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticonvulsant-induced lymphoma.
    Fried MP; Sunwoo Y
    Laryngoscope; 1975 Oct; 85(10):1770-81. PubMed ID: 1186408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is phenytoin carcinogenic?
    Lancet; 1971 Nov; 2(7733):1071-2. PubMed ID: 4106919
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.
    Olsen JH; Schulgen G; Boice JD; Whysner J; Travis LB; Williams GM; Johnson FB; McGee JO
    Cancer Res; 1995 Jan; 55(2):294-7. PubMed ID: 7812960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudolymphoma induced by diphenylhydantoin.
    Gams RA
    J Pediatr; 1970 Dec; 77(6):1100-1. PubMed ID: 5486632
    [No Abstract]   [Full Text] [Related]  

  • 7. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical side effects of phenytoin therapy].
    Poppe W; Krauspe M
    Dtsch Gesundheitsw; 1968 Apr; 23(15):715-9. PubMed ID: 5679439
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary lymphoma of the spleen: echographic diagnosis].
    Fernández-Martínez A; De La Revilla L; Sánchez Chicon A; Cabrera A; Ruiz Martín N; García Requena L; Salinas C
    Rev Clin Esp; 1981 Aug 15-31; 162(3-4):165-7. PubMed ID: 7313210
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
    Sigal M; Pulik M
    Ann Dermatol Venereol; 1993; 120(2):175-80. PubMed ID: 8363313
    [No Abstract]   [Full Text] [Related]  

  • 11. An unusual dual hypersensitivity reaction induced by diphenylhydantoin.
    Sisca TS
    Am J Hosp Pharm; 1973 May; 30(5):446-9. PubMed ID: 4267436
    [No Abstract]   [Full Text] [Related]  

  • 12. Dilantin jeopardy: avoiding the dangers of phenytoin.
    Schlicher ML
    Medsurg Nurs; 1998 Dec; 7(6):343-7, 356. PubMed ID: 10036438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)].
    Matsuo T; Matsumoto A; Miyasaki K
    Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant lymphoma after diphenylhydantoin (dilantin) therapy.
    Li FP; Willard DR; Goodman R; Vawter G
    Cancer; 1975 Oct; 36(4):1359-62. PubMed ID: 1175133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated malignant lymphoma of the jejunum and long-term diphenylhydantoin therapy.
    Rubinstein I; Langevitz P; Shibi G
    Oncology; 1985; 42(2):104-6. PubMed ID: 3887259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic vasculitis associated with long-term phenytoin therapy.
    Holt P
    N Z Med J; 1999 Mar; 112(1084):100. PubMed ID: 10210297
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
    Brostoff JM; Birns J; McCrea D
    J Clin Pharm Ther; 2008 Apr; 33(2):211-4. PubMed ID: 18315788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogeusia as an adverse reaction of phenytoin.
    Baumann CR; Ott PM; Siegel AM
    Br J Clin Pharmacol; 2004 Dec; 58(6):678-9. PubMed ID: 15563368
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone disease induced by phenytoin therapy: clinical and experimental study.
    Moro-Alvarez MJ; Díaz Curiel M; de la Piedra C; Mariñoso ML; Carrascal MT
    Eur Neurol; 2009; 62(4):219-30. PubMed ID: 19628941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.